InvestorsHub Logo
icon url

Steady_T

10/20/17 12:13 PM

#125531 RE: XenaLives #125529

Good point. My guess is because there is such a long way to go before getting into human trials that Bio would do some sort of license to ameliorate the risk of an outright purchase relating to MS.